H-Arg(Pbf)-OH

H-Arg(Pbf)-OH is an arginine amino acid derivative bearing a free carboxylic acid and an N-terminal amino group protected as an amidine-compatible Pbf (2,2,4,6,7-pentamethyl-2,3-dihydrobenzofuran) carbamimidoyl protecting group. The molecule retains the native arginine stereocenter at the α-carbon (commonly used as the L-configuration in peptide synthesis), while the side-chain guanidinium functionality is masked to reduce undesired salt formation and side reactions during coupling and deprotection workflows. The Pbf group provides acid-labile protection that can be removed under conditions commonly employed for protected amino acid synthesis, enabling controlled regeneration of the guanidinium group for downstream peptide assembly. The combination of a protected guanidine side chain with a reactive α-amino acid backbone makes H-Arg(Pbf)-OH a chiral, peptide-compatible intermediate for guanidinium-bearing sequences and for synthetic modifications that depend on orthogonal protection strategies.

1. Protected Amino Acids

H-Arg(Pbf)-OH is used in protected amino acid synthesis and peptide building block preparation where arginine side-chain chemoselectivity is required during Nα activation and coupling. The Pbf-protected guanidinium side chain minimizes strong ionic interactions and can improve handling of the amino acid during standard peptide coupling chemistry, while the free α-carboxylic acid supports conversion to activated derivatives for incorporation into growing chains. Acid-labile Pbf deprotection can be applied to regenerate the guanidinium functionality after peptide assembly, enabling controlled exposure of the basic side chain for subsequent derivatization or purification-focused workflows. The resulting deprotected arginine residue participates in hydrogen bonding and electrostatic recognition in peptide contexts, supporting downstream scaffold construction in amino acid chemistry and peptide science.

2. Peptide Synthesis

H-Arg(Pbf)-OH is suitable for solid-phase peptide synthesis and solution-phase peptide coupling when guanidinium-bearing residues must be introduced with minimized side reactions. The protected amidine/guanidine motif helps maintain compatibility with common coupling reagents by reducing nucleophilicity of the side chain and limiting competing reactions during amide bond formation at the α-amino group. The α-amino acid architecture supports sequential chain elongation, while the stereodefined α-carbon preserves the stereochemical integrity required for arginine-containing peptide sequences. Post-assembly Pbf removal yields an unmasked guanidinium side chain that can contribute to salt formation, protease recognition patterns, and binding site electrostatics, making H-Arg(Pbf)-OH a practical intermediate for peptide analog construction and peptide library synthesis.

3. Bioconjugation Chemistry

H-Arg(Pbf)-OH can be applied in bioconjugation and chemical biology workflows that require controlled installation of arginine-like cationic motifs after peptide or linker assembly. The Pbf-protected guanidinium group functions as a masked, deprotection-triggered handle, enabling conjugation strategies that depend on exposing a strongly basic side chain only at a chosen stage of synthesis. The free carboxylic acid and protected amine facilitate incorporation into peptide-based linkers, which can then be deprotected to generate guanidinium residues for electrostatic interactions with nucleic acids, glycans, or negatively charged biomolecular surfaces. The stereodefined arginine residue supports formation of well-defined cationic microenvironments in conjugates, supporting downstream molecular recognition studies and applied biomolecule modification.

4. Structure-Activity Relationship Studies

H-Arg(Pbf)-OH is used in structure-activity relationship (SAR) studies and molecular design efforts where arginine side-chain charge presentation must be tuned through protected amino acid incorporation. The Pbf group enables synthesis of arginine-containing analogs without premature guanidinium exposure, supporting systematic variation of peptide length, sequence context, and local basicity after controlled deprotection. The stereochemical fidelity at the α-carbon helps ensure that observed changes in physicochemical behavior or binding-related properties can be attributed to sequence modifications rather than racemization artifacts. The resulting guanidinium-bearing peptides or peptidomimetic fragments can serve as defined inputs for SAR workflows, enabling iterative refinement of cationic recognition elements in amino acid and peptide science.

5. Pharmaceutical Manufacturing

H-Arg(Pbf)-OH can be employed as a process-relevant protected amino acid intermediate in the manufacturing of peptide-based active ingredients or peptide intermediates used in pharmaceutical production. The Pbf-protected guanidinium side chain is compatible with protected amino acid strategies that aim to manage solubility, minimize side reactions, and support reproducible deprotection steps during large-scale peptide synthesis. The molecule's defined stereochemistry and functional group set (α-amino protection, free carboxyl group, and masked guanidinium) align with industrially scalable peptide coupling and purification workflows that require predictable functional group behavior. Downstream, deprotected arginine residues generated from H-Arg(Pbf)-OH can be incorporated into final peptide products or into intermediates for further derivatization, supporting industrial chemistry pipelines for fine chemical synthesis and specialty pharmaceutical manufacturing.

1. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

2. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum

5. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle